Pregnancy is associated with many physiologic and hormonal changes along with changes in sleep architecture, placing pregnant women at risk for the development of sleep-disordered breathing or worsening of preexisting sleep apnea. Snoring, the most common symptom of sleep-disordered breathing, is markedly increased during pregnancy. The exact prevalence of obstructive sleep apnea in pregnant women is unknown. Because the apneic episodes are commonly associated with oxyhemoglobin desaturations, the combination of obstructive sleep apnea and pregnancy can be potentially harmful to the fetus given the low oxygen reserves during pregnancy. Obstructive sleep apnea has been associated with an increased risk of hypertension among the general population, and this raises the possibility of its association with gestational hypertension and preeclampsia. In this clinical review, we discuss the physiologic changes of pregnancy that predispose pregnant women to the development of obstructive sleep apnea and the effects of sleep-disordered breathing on pregnancy outcomes. We also review the recom- Sleep-disordered breathing (SDB) includes snoring, upper airway resistance syndrome, and obstructive sleep apnea (OSA)-hypopnea syndrome. OSA-hypopnea syndrome is characterized by recurrent episodes of upper airway collapse and obstruction during sleep and is associated with recurrent oxygen desaturations and arousals from sleep. These disorders represent a continuum of SDB, with snoring at one end of the spectrum and OSAhypopnea syndrome at the other end. The exact prevalence of OSA among pregnant women is unknown. The prevalence of OSA is estimated to be 5% to 6% among women of reproductive age.